3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
16
Oropharyngeal Neoplasms
10
Nasopharyngeal Carcinoma
10
Prostatic Neoplasms
7
Laryngeal Neoplasms
6
Rectal Neoplasms
5
Mouth Neoplasms
5
Hypopharyngeal Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma
5
Carcinoma, Non-Small-Cell Lung
4
Esophageal Neoplasms
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nasopharyngeal Neoplasms
2
Mesothelioma
2
Epstein-Barr Virus Infections
2
Carcinoma, Intraductal, Noninfiltrating
2
Astrocytoma
2
Anus Neoplasms
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomatitis
1
Stomach Neoplasms
1
Interventions
Specimen Handling
45
pembrolizumab
41
Biopsy
37
Magnetic Resonance Spectroscopy
35
Nivolumab
21
Paclitaxel
20
Gemcitabine
20
Radiosurgery
19
Carboplatin
19
Irinotecan
14
Ipilimumab
13
Cisplatin
12
Capecitabine
12
130-nm albumin-bound paclitaxel
12
Taxes
11
Pemetrexed
11
trastuzumab deruxtecan
10
olaparib
10
Leucovorin
10
Fluorouracil
10
Oxaliplatin
9
Fulvestrant
9
Cyclophosphamide
9
Cetuximab
9
durvalumab
8
abemaciclib
8
X-Rays
8
Drug Therapy
8
Bevacizumab
8
palbociclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Radiotherapy, Intensity-Modulated
×
90 days
×
Clear all
NCT07423078
2026-04-13
WOLF
University of Pittsburgh
Phase 2
Recruiting
87 enrolled